← Search & browse all drugs
ALIMENTARY TRACT AND METABOLISM › OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS › OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS › Amino acids and derivatives
glutamine
A16AA03
Forms & Strengths
- Oral powder: 5 g per packet
- Oral powder: 7.5 g per packet
- Oral powder: 10 g per packet
- Oral powder for reconstitution: 100% amino acid
Adult Dosing
- Short bowel syndrome: Oral 0.5 g/kg/day divided into three doses with meals
- Sickle cell disease: Oral 0.1 g/kg (max 30 g/day) divided twice daily
Pediatric Dosing
- Sickle cell disease (Patients >= 5 years): Oral 0.1 g/kg (max 30 g/day) divided twice daily
- Short bowel syndrome (Safety/efficacy not fully established, adult dosing extrapolated by weight in clinical practice)
Indications
- Reduction of acute complications of sickle cell disease
- Adjunctive dietary management of short bowel syndrome
Mechanism of Action
- Serves as a conditionally essential amino acid and precursor for nitrogen and carbon donors
- Increases the nadh/nad ratio in erythrocytes, reducing oxidative stress and preventing sickle red blood cell damage
Contraindications
- Hypersensitivity to L-glutamine or excipients
- Severe hepatic impairment (theoretical risk of worsening encephalopathy)
Adverse Reactions
- Constipation
- Nausea
- Headache
- Abdominal pain
- Cough
- Pain in extremity
Drug Interactions
- No formal drug-drug interaction studies performed
- May potentially interact with other nitrogen-metabolizing agents
Curated Content: Needs Vetting Before Put to Clinical Use